Moderna’s mysterious coronavirus vaccine delivery system

29 July 2020 - For a decade, Moderna has been working to develop mRNA technology that could turn the body’s cells ...

Read more →

Coronavirus puts big pharma’s IP regime to the test

21 April 2020 - “Chaotic” is how Jorge Contreras, a law professor at the University of Utah, describes a struggle ...

Read more →

Expanding access and reducing prices for drugs to prevent HIV. Should Government enforce its patent rights against the pharmaceutical industry?

3 March 2020 - On November 6, 2019, the Department of Health and Human Services (HHS) filed a lawsuit against Gilead ...

Read more →

Institutional investors urging Congress to vote down CUSMA, citing effect on drug prices

23 September 2019 - A group of institutional investors representing more than US$500 billion is calling on the U.S. Congress ...

Read more →

Big Pharma is abusing patents, and it's hurting Americans

12 September 2019 - The American patent system has, since our nation's founding, served as a cornerstone of innovation. But ...

Read more →

Subscription model for antibiotic development

6 September 2019 - An unlikely answer to the global crisis in antibiotic resistance. ...

Read more →

Gilead files challenge to government patents for HIV prevention pill

21 August 2019 - Gilead Sciences took the unusual step of mounting a challenge to U.S. government patents on Wednesday, ...

Read more →

Chinese stealing health and medical research data: report

21 August 2019 - The global healthcare sector, including Australia, faces increasing cyber threats and malicious activity from Chinese groups, ...

Read more →

Is ‘competitive licensing’ proposed in HR 1046 practical for lowering drug prices?

29 July 2019 - The pricing of prescription drugs is a source of current public consternation in the US.  ...

Read more →

Intellectual property law amends will add to business uncertainty

26 July 2019 - Medicines Australia supports efforts to strengthen Australia’s Intellectual Property arrangements to be consistent with international best ...

Read more →

How pharma, under attack from all sides, keeps winning in Washington

16 July 2019 - It does not seem to matter how angrily President Trump tweets, how pointedly House Speaker Nancy ...

Read more →

With eyes on Gilead, law makers want details on how HHS reviews possible patent infringement

18 June 2019 - A pair of law makers has asked the Government Accountability Office to review how the U.S. ...

Read more →

They were supposed to talk about the patent system driving up drug prices. But most lawmakers got distracted by small tweaks.

7 May 2019 - If there was any hope that Congress might overhaul the way this country doles out the ...

Read more →

Pharmaceutical protections in U.S. trade deals — what do Americans get in return?

1 May 2019 - U.S. trade deals increasingly include terms affecting the approval process and availability of medicines.  ...

Read more →

Drug company protections are latest stumbling block for NAFTA rewrite

21 March 2019 - President Trump’s ability to get his revised North American Free Trade Agreement through Congress may hinge ...

Read more →